Wang Lai (CIK 1852291) reported 28 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-25). Recent activity: Sell ONC (1,068 shares), Sell ONC (1,169 shares), Sell ONC (1,327 shares), Sell ONC (40 shares), Buy ONC (112,606 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-25 | BeOne Medicines Ltd. (ONC) | President, Global Head of R&D | Sell | 1,068 | $295,553 |
| 2026-06-18 | BeOne Medicines Ltd. (ONC) | President, Global Head of R&D | Sell | 1,169 | $310,236 |
| 2026-06-10 | BeOne Medicines Ltd. (ONC) | President, Global Head of R&D | Sell | 1,327 | $357,418 |
| 2026-06-10 | BeOne Medicines Ltd. (ONC) | President, Global Head of R&D | Sell | 40 | $10,829 |
| 2026-03-10 | BeOne Medicines Ltd. (ONC) | President, Global Head of R&D | Buy | 112,606 | $0 |
| 2026-03-10 | BeOne Medicines Ltd. (ONC) | President, Global Head of R&D | Buy | 55,029 | $0 |
| 2026-01-05 | BeOne Medicines Ltd. (ONC) | President, Global Head of R&D | Buy | 427,895 | $0 |
| 2025-09-11 | BeOne Medicines Ltd. (ONC) | Global Head of R&D | Sell | 5,000 | $1.8M |
| 2025-07-31 | BeOne Medicines Ltd. (ONC) | Global Head of R&D | Sell | 2,949 | $890,598 |
| 2025-07-31 | BeOne Medicines Ltd. (ONC) | Global Head of R&D | Sell | 292 | $88,453 |
| 2025-07-31 | BeOne Medicines Ltd. (ONC) | Global Head of R&D | Sell | 800 | $243,328 |
| 2025-07-31 | BeOne Medicines Ltd. (ONC) | Global Head of R&D | Sell | 259 | $78,995 |
| 2025-07-22 | BeOne Medicines Ltd. (ONC) | Global Head of R&D | Sell | 700 | $210,000 |
| 2025-06-25 | BeOne Medicines Ltd. (ONC) | Global Head of R&D | Sell | 1,028 | $267,280 |
| 2025-06-18 | BeOne Medicines Ltd. (ONC) | Global Head of R&D | Sell | 1,177 | $313,553 |
| 2025-06-18 | BeOne Medicines Ltd. (ONC) | Global Head of R&D | Sell | 470 | $118,144 |
| 2025-06-12 | BeOne Medicines Ltd. (ONC) | Global Head of R&D | Buy | 86,359 | $0 |
| 2025-06-10 | BeOne Medicines Ltd. (ONC) | Global Head of R&D | Sell | 600 | $150,426 |
| 2025-06-10 | BeOne Medicines Ltd. (ONC) | Global Head of R&D | Sell | 202 | $50,882 |
| 2025-06-10 | BeOne Medicines Ltd. (ONC) | Global Head of R&D | Sell | 300 | $75,957 |
| 2025-06-10 | BeOne Medicines Ltd. (ONC) | Global Head of R&D | Sell | 300 | $76,590 |
| 2025-03-07 | BeiGene, Ltd. (BGNE) | Global Head of R&D | Buy | 69,251 | $0 |
| 2025-02-25 | BeiGene, Ltd. (BGNE) | Global Head of R&D | Sell | 1,327 | $338,146 |
| 2025-02-25 | BeiGene, Ltd. (BGNE) | Global Head of R&D | Sell | 575 | $147,120 |
| 2025-02-25 | BeiGene, Ltd. (BGNE) | Global Head of R&D | Sell | 479 | $122,959 |
Source: SEC Form 4 filings · as of 2026-06-25